372 related articles for article (PubMed ID: 27638601)
21. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
Biffi A; Montini E; Lorioli L; Cesani M; Fumagalli F; Plati T; Baldoli C; Martino S; Calabria A; Canale S; Benedicenti F; Vallanti G; Biasco L; Leo S; Kabbara N; Zanetti G; Rizzo WB; Mehta NA; Cicalese MP; Casiraghi M; Boelens JJ; Del Carro U; Dow DJ; Schmidt M; Assanelli A; Neduva V; Di Serio C; Stupka E; Gardner J; von Kalle C; Bordignon C; Ciceri F; Rovelli A; Roncarolo MG; Aiuti A; Sessa M; Naldini L
Science; 2013 Aug; 341(6148):1233158. PubMed ID: 23845948
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy for metachromatic leukodystrophy.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Matalon R; Eto Y
Acta Paediatr Jpn; 1996 Apr; 38(2):193-201. PubMed ID: 8677802
[TBL] [Abstract][Full Text] [Related]
23. Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy.
Capotondo A; Cesani M; Pepe S; Fasano S; Gregori S; Tononi L; Venneri MA; Brambilla R; Quattrini A; Ballabio A; Cosma MP; Naldini L; Biffi A
Hum Gene Ther; 2007 Sep; 18(9):821-36. PubMed ID: 17845130
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy.
Simonis H; Yaghootfam C; Sylvester M; Gieselmann V; Matzner U
Hum Mol Genet; 2019 Jun; 28(11):1810-1821. PubMed ID: 30657900
[TBL] [Abstract][Full Text] [Related]
25. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
[TBL] [Abstract][Full Text] [Related]
26. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
[TBL] [Abstract][Full Text] [Related]
28. Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
Miyake N; Miyake K; Asakawa N; Yamamoto M; Shimada T
Gene Ther; 2014 Apr; 21(4):427-33. PubMed ID: 24572788
[TBL] [Abstract][Full Text] [Related]
29. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
[TBL] [Abstract][Full Text] [Related]
30. Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD).
Dorboz I; Eymard-Pierre E; Kefi R; Abdelhak S; Miladi N; Boespflug-Tanguy O;
J Neurol Sci; 2009 Dec; 287(1-2):278-80. PubMed ID: 19699491
[TBL] [Abstract][Full Text] [Related]
31. Correction of enzyme deficiency in metachromatic leukodystrophy fibroblasts by retroviral-mediated transfer of the human arylsulphatase A gene.
Ohashi T; Eto Y; Learish R; Barranger JA
J Inherit Metab Dis; 1993; 16(5):881-5. PubMed ID: 7905036
[No Abstract] [Full Text] [Related]
32. [Metachromatic leukodystrophy (MLD) and Multiple sulphatase deficiency (MSD)].
Eto Y; Hasegawa Y; Tsuda T
Nihon Rinsho; 1995 Dec; 53(12):2994-3003. PubMed ID: 8577048
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of arylsulfatase A pseudodeficiency allele in metachromatic leukodystrophy patients from Poland.
Lugowska A; Czartoryska B; Tylki-Szymańska A; Bisko M; Zimowski JG; Berger J; Molzer B
Eur Neurol; 2000; 44(2):104-7. PubMed ID: 10965162
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy of metachromatic leukodystrophy.
Matzner U; Gieselmann V
Expert Opin Biol Ther; 2005 Jan; 5(1):55-65. PubMed ID: 15709909
[TBL] [Abstract][Full Text] [Related]
35. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24.
Tsutsudaasano A; Migita M; Takahashi K; Shimada T
J Hum Genet; 2000; 45(1):18-23. PubMed ID: 10697958
[TBL] [Abstract][Full Text] [Related]
36. [Metachromatic Leukodystrophy (MLD): MRI findings].
Fenchel M; Hauser TK; Nägele T; Ernemann U; Horger M
Rofo; 2011 Oct; 183(10):893-5. PubMed ID: 22232791
[No Abstract] [Full Text] [Related]
37. Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD).
Eng B; Nakamura LN; O'Reilly N; Schokman N; Nowaczyk MM; Krivit W; Waye JS
Hum Mutat; 2003 Nov; 22(5):418-9. PubMed ID: 14517960
[TBL] [Abstract][Full Text] [Related]
38. Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy.
Kohlschütter A
Handb Clin Neurol; 2013; 113():1611-8. PubMed ID: 23622382
[TBL] [Abstract][Full Text] [Related]
39. Medicine. Gene therapy that works.
Verma IM
Science; 2013 Aug; 341(6148):853-5. PubMed ID: 23970689
[No Abstract] [Full Text] [Related]
40. Gene therapy for leukodystrophies.
Biffi A; Aubourg P; Cartier N
Hum Mol Genet; 2011 Apr; 20(R1):R42-53. PubMed ID: 21459776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
